ARMODAFINIL Side Effects

6962108-6 | Lip Swelling, Ocular Hyperaemia, Odynophagia, Oropharyngeal Blistering, Oropharyngeal Pain, Pruritus, Rash, Upper Respiratory Tract Infection
on Sep 01, 2010 Female patient from UNITED STATES , 15 years of age, weighting 108.0 lb, was diagnosed with sleep paralysis and was treated with Armodafinil (View Usage). Patient experienced the following unwanted or unexpected effects: lip swelling, ocular hyperaemia, odynophagia, oropharyngeal blistering, oropharyngeal pain, pruritus, rash (What is rash?), upper respiratory tract infection. Armodafinil dosage: 150mg Daily Po. Patient was hospitalized.

6083532-2 | Rash Morbilliform
Patient was taking Armodafinil (View Usage). Patient had the following side effects: rash morbilliform on Feb 04, 2009 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 158.4 lb, was diagnosed with schizophrenia and. Armodafinil dosage: 250 Mg Qam Oral. During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

6083486-9 | Rash Morbilliform, Rash Papular
Adverse event was reported on Feb 04, 2009 by a Male patient taking Armodafinil (View Usage) (Dosage: 250 Mg Qam Oral) was diagnosed with schizophrenia and. Location: UNITED STATES , 49 years of age, weighting 158.4 lb, After Armodafinil was administered, patient had the following side effects: rash morbilliform, rash papular. During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

6076341-1 | Folliculitis
on Jan 29, 2009 Male patient from UNITED STATES , 46 years of age, weighting 221.0 lb, was diagnosed with major depression, sleep apnoea syndrome, somnolence and was treated with Armodafinil (View Usage). Patient experienced the following unwanted or unexpected effects: folliculitis. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).


6074996-9 | Folliculitis
on Jan 29, 2009 Male patient from UNITED STATES , 46 years of age, weighting 221.0 lb, was diagnosed with major depression, sleep apnoea syndrome, somnolence and was treated with Armodafinil (View Usage). Patient had the following side effects: folliculitis. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

6063906-6 | Rash Erythematous, Rash Morbilliform, Rash Papular
Patient was taking Armodafinil (View Usage). After Armodafinil was administered, patient had the following side effects: rash erythematous, rash morbilliform, rash papular on Jan 22, 2009 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 158.4 lb, was diagnosed with schizophrenia and. Armodafinil dosage: 250 Mg Qam Oral. During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

6025852-3 | Rash Morbilliform
Adverse event was reported on Dec 17, 2008 by a Male patient taking Armodafinil (View Usage) (Dosage: 250 Mg Qam Oral) was diagnosed with schizophrenia and. Location: UNITED STATES , 49 years of age, weighting 158.4 lb, Patient experienced the following unwanted or unexpected effects: rash morbilliform. During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

6025812-2 | Rash Erythematous, Rash Morbilliform, Rash Papular, Skin Reaction
on Dec 17, 2008 Male patient from UNITED STATES , 49 years of age, weighting 158.4 lb, was diagnosed with schizophrenia and was treated with Armodafinil (View Usage). Patient had the following side effects: rash erythematous, rash morbilliform, rash papular, skin reaction. Armodafinil dosage: 250 Mg Qam Oral. During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

6019940-5 | Rash Erythematous, Rash Morbilliform, Rash Papular
on Dec 10, 2008 Male patient from UNITED STATES , 49 years of age, weighting 158.4 lb, was diagnosed with schizophrenia and was treated with Armodafinil (View Usage). After Armodafinil was administered, patient had the following side effects: rash erythematous, rash morbilliform, rash papular. Armodafinil dosage: 250 Mg Qam Oral. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

5977012-X | Condition Aggravated, Dermatitis Allergic, Eczema, Excoriation, Hypersensitivity, Rash Papular, Schizophrenia
Patient was taking Armodafinil (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, dermatitis allergic, eczema (What is eczema?), excoriation, hypersensitivity, rash papular, schizophrenia on Nov 14, 2008 from UNITED STATES Additional patient health information: Male patient , 34 years of age, weighting 175.0 lb, was diagnosed with schizophrenia and. Armodafinil dosage: 150 Mg Qd Oral. During the same period patient was treated with TRIAMCINOLONE (Bid) (View Triamcinolone Review and Triamcinolone Label ), BUDESONIDE WITH FORMOTEROL (View Budesonide With Formoterol Review and Budesonide With Formoterol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SIMVACOR (View Simvacor Review and Simvacor Label ), COGENTIN (View Cogentin Review and Cogentin Label ), PALIPERIDONE (View Paliperidone Review and Paliperidone Label ), VARENICLINE (View Varenicline Review and Varenicline Label ). Patient was hospitalized.

5941639-1 | Erythema, Folliculitis, Rash Maculo-papular, Rash Papular, Rash Pruritic
Adverse event was reported on Oct 13, 2008 by a Male patient taking Armodafinil (View Usage) (Dosage: 250 Mg Qd Oral) was diagnosed with major depression, sleep apnoea syndrome, somnolence and. Location: UNITED STATES , 46 years of age, weighting 221.0 lb, Patient had the following side effects: erythema, folliculitis, rash maculo-papular, rash papular, rash pruritic. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

5939511-6 | Folliculitis
on Oct 22, 2008 Male patient from UNITED STATES , 46 years of age, weighting 221.0 lb, was diagnosed with major depression, sleep apnoea syndrome, somnolence and was treated with Armodafinil (View Usage). After Armodafinil was administered, patient had the following side effects: folliculitis. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

5933826-3 | Folliculitis, Rash Papular, Rash Pruritic
on Oct 13, 2008 Male patient from UNITED STATES , 46 years of age, weighting 221.0 lb, was diagnosed with major depression, sleep disorder (What is sleep disorder?), somnolence and was treated with Armodafinil (View Usage). Patient experienced the following unwanted or unexpected effects: folliculitis, rash papular, rash pruritic. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

5927751-1 | Agitation, Condition Aggravated, Schizophrenia
Patient was taking Armodafinil (View Usage). Patient had the following side effects: agitation, condition aggravated, schizophrenia on Oct 02, 2008 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 192.2 lb, was diagnosed with schizophrenia and. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

5894318-3 | Pruritus, Rash, Rash Papular, Skin Exfoliation, Skin Lesion, Urticaria
Adverse event was reported on Aug 29, 2008 by a Female patient taking Armodafinil (View Usage) (Dosage: 150 Mg Qam Oral) was diagnosed with schizoaffective disorder, schizophrenia and. Location: UNITED STATES , 41 years of age, weighting 218.0 lb, After Armodafinil was administered, patient had the following side effects: pruritus, rash (What is rash?), rash papular, skin exfoliation, skin lesion, urticaria. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), COMBIVENT (View Combivent Review and Combivent Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5894288-8 | Pruritus, Rash, Skin Exfoliation, Skin Lesion, Treatment Failure, Urticaria
on Aug 29, 2008 Female patient from UNITED STATES , 41 years of age, weighting 218.0 lb, was diagnosed with schizoaffective disorder, schizophrenia and was treated with Armodafinil (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?), skin exfoliation, skin lesion, treatment failure, urticaria. Armodafinil dosage: 150 Mg Qam Oral. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), COMBIVENT (View Combivent Review and Combivent Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

5892287-3 | Rash Erythematous
on Sep 09, 2008 Male patient from UNITED STATES , 46 years of age, weighting 221.0 lb, was diagnosed with major depression, sleep apnoea syndrome, somnolence and was treated with Armodafinil (View Usage). Patient had the following side effects: rash erythematous. Armodafinil dosage: 250 Mg Qd Oral. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

5605488-6 | Dyskinesia
Patient was taking Armodafinil (View Usage). After Armodafinil was administered, patient had the following side effects: dyskinesia on Jan 24, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 177.0 lb, was diagnosed with investigation and. Armodafinil dosage: 150 Mg Daily. During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ).